Biliverdin Reductase: a Target for Cancer Therapy?
Biliverdin reductase (BVR) is a multifunctional protein that is the primary source of the potent antioxidant, bilirubin. BVR regulates activities/functions in the insulin/IGF-1/IRK/PI3K/MAPK pathways. Activation of certain kinases in these pathways is/are hallmark(s) of cancerous cells. The prote...
Main Authors: | Peter eGibbs, Tihomir eMiralem, Mahin D Maines |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00119/full |
Similar Items
-
Biliverdin reductase: more than a namesakeThe reductase, its peptide fragments and biliverdin regulate activity of the three classes of protein kinase C.
by: Peter E.M. Gibbs, et al.
Published: (2012-03-01) -
Direct antioxidant properties of bilirubin andbiliverdin. Is there a role for biliverdin reductase?
by: Thomas eJansen, et al.
Published: (2012-03-01) -
Subarachnoid Hemorrhage Increases Level of Heme Oxygenase-1 and Biliverdin Reductase in the Choroid Plexus
by: Peter Solár, et al.
Published: (2020-11-01) -
The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: It's time for reconciliation
by: Eugenio Barone, et al.
Published: (2014-02-01) -
Scalable production of biliverdin IXα by <it>Escherichia coli</it>
by: Chen Dong, et al.
Published: (2012-11-01)